IL‐17 cytokines, already associated with a plethora of immune‐mediated inflammatory skin diseases [49], exert a multitude of pro‐inflammatory effects, and in the pathogenic scenario of SS, could further increase IL‐17 production and immune cell infiltrations in a feed‐forward inflammatory loop. This evidence concerns the gene IL17A and synovial sarcoma.